Cargando…

Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme

Organophosphorus (OP) nerve agents are potent suicide inhibitors of the essential neurotransmitter-regulating enzyme acetylcholinesterase. Due to their acute toxicity, there is significant interest in developing effective countermeasures to OP poisoning. Here we impart nerve agent hydrolysis activit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemmert, Andrew C., Otto, Tamara C., Chica, Roberto A., Wierdl, Monika, Edwards, Jonathan S., Lewis, Steven L., Edwards, Carol C., Tsurkan, Lyudmila, Cadieux, C. Linn, Kasten, Shane A., Cashman, John R., Mayo, Stephen L., Potter, Philip M., Cerasoli, Douglas M., Redinbo, Matthew R.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060870/
https://www.ncbi.nlm.nih.gov/pubmed/21445272
http://dx.doi.org/10.1371/journal.pone.0017441
_version_ 1782200554895704064
author Hemmert, Andrew C.
Otto, Tamara C.
Chica, Roberto A.
Wierdl, Monika
Edwards, Jonathan S.
Lewis, Steven L.
Edwards, Carol C.
Tsurkan, Lyudmila
Cadieux, C. Linn
Kasten, Shane A.
Cashman, John R.
Mayo, Stephen L.
Potter, Philip M.
Cerasoli, Douglas M.
Redinbo, Matthew R.
author_facet Hemmert, Andrew C.
Otto, Tamara C.
Chica, Roberto A.
Wierdl, Monika
Edwards, Jonathan S.
Lewis, Steven L.
Edwards, Carol C.
Tsurkan, Lyudmila
Cadieux, C. Linn
Kasten, Shane A.
Cashman, John R.
Mayo, Stephen L.
Potter, Philip M.
Cerasoli, Douglas M.
Redinbo, Matthew R.
author_sort Hemmert, Andrew C.
collection PubMed
description Organophosphorus (OP) nerve agents are potent suicide inhibitors of the essential neurotransmitter-regulating enzyme acetylcholinesterase. Due to their acute toxicity, there is significant interest in developing effective countermeasures to OP poisoning. Here we impart nerve agent hydrolysis activity into the human drug metabolism enzyme carboxylesterase 1. Using crystal structures of the target enzyme in complex with nerve agent as a guide, a pair of histidine and glutamic acid residues were designed proximal to the enzyme's native catalytic triad. The resultant variant protein demonstrated significantly increased rates of reactivation following exposure to sarin, soman, and cyclosarin. Importantly, the addition of these residues did not alter the high affinity binding of nerve agents to this protein. Thus, using two amino acid substitutions, a novel enzyme was created that efficiently converted a group of hemisubstrates, compounds that can start but not complete a reaction cycle, into bona fide substrates. Such approaches may lead to novel countermeasures for nerve agent poisoning.
format Text
id pubmed-3060870
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30608702011-03-28 Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme Hemmert, Andrew C. Otto, Tamara C. Chica, Roberto A. Wierdl, Monika Edwards, Jonathan S. Lewis, Steven L. Edwards, Carol C. Tsurkan, Lyudmila Cadieux, C. Linn Kasten, Shane A. Cashman, John R. Mayo, Stephen L. Potter, Philip M. Cerasoli, Douglas M. Redinbo, Matthew R. PLoS One Research Article Organophosphorus (OP) nerve agents are potent suicide inhibitors of the essential neurotransmitter-regulating enzyme acetylcholinesterase. Due to their acute toxicity, there is significant interest in developing effective countermeasures to OP poisoning. Here we impart nerve agent hydrolysis activity into the human drug metabolism enzyme carboxylesterase 1. Using crystal structures of the target enzyme in complex with nerve agent as a guide, a pair of histidine and glutamic acid residues were designed proximal to the enzyme's native catalytic triad. The resultant variant protein demonstrated significantly increased rates of reactivation following exposure to sarin, soman, and cyclosarin. Importantly, the addition of these residues did not alter the high affinity binding of nerve agents to this protein. Thus, using two amino acid substitutions, a novel enzyme was created that efficiently converted a group of hemisubstrates, compounds that can start but not complete a reaction cycle, into bona fide substrates. Such approaches may lead to novel countermeasures for nerve agent poisoning. Public Library of Science 2011-03-18 /pmc/articles/PMC3060870/ /pubmed/21445272 http://dx.doi.org/10.1371/journal.pone.0017441 Text en Hemmert et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Hemmert, Andrew C.
Otto, Tamara C.
Chica, Roberto A.
Wierdl, Monika
Edwards, Jonathan S.
Lewis, Steven L.
Edwards, Carol C.
Tsurkan, Lyudmila
Cadieux, C. Linn
Kasten, Shane A.
Cashman, John R.
Mayo, Stephen L.
Potter, Philip M.
Cerasoli, Douglas M.
Redinbo, Matthew R.
Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme
title Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme
title_full Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme
title_fullStr Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme
title_full_unstemmed Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme
title_short Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme
title_sort nerve agent hydrolysis activity designed into a human drug metabolism enzyme
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060870/
https://www.ncbi.nlm.nih.gov/pubmed/21445272
http://dx.doi.org/10.1371/journal.pone.0017441
work_keys_str_mv AT hemmertandrewc nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT ottotamarac nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT chicarobertoa nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT wierdlmonika nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT edwardsjonathans nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT lewisstevenl nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT edwardscarolc nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT tsurkanlyudmila nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT cadieuxclinn nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT kastenshanea nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT cashmanjohnr nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT mayostephenl nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT potterphilipm nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT cerasolidouglasm nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme
AT redinbomatthewr nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme